Circadian Rhythm Support.

Melatonin binds MT1 and MT2 receptors in the suprachiasmatic nucleus, which is the clock signal that shifts the timing of the sleep phase. Every other member of a circadian blend either feeds its synthesis or lowers arousal so the signal can land.

Tryptophan is hydroxylated to 5-HTP, decarboxylated to serotonin, then acetylated and methylated to melatonin in the pineal gland. Supplying the head of that chain supports the body's own evening melatonin rise.

5-HTP skips the rate-limiting tryptophan hydroxylase step and is decarboxylated straight to serotonin, the direct precursor of melatonin. It feeds the same evening pathway from a later point.

Aromatic L-amino acid decarboxylase, the enzyme that converts 5-HTP to serotonin, needs pyridoxal-5-phosphate as its cofactor. Without adequate B6 the precursor step in a circadian blend runs slowly.

Magnesium sits in the NMDA receptor channel as a voltage-dependent block and supports GABA-A signalling, which lowers evening neural excitability. The glycine carrier itself is an inhibitory amino acid, so the salt contributes on both halves.

Glycine acts at its own inhibitory receptor and at the NMDA glycine site, and it lowers core body temperature through peripheral vasodilation. The evening temperature drop is part of the normal signal the clock uses for sleep onset.

Theanine is a glutamate analogue that lowers excitatory transmission and raises alpha band activity without sedation. It reduces evening arousal, so a timing signal such as melatonin is not working against a stimulated state.

Apigenin, the main flavone of chamomile, binds the benzodiazepine site of the GABA-A receptor with modest affinity. That lowers neuronal excitability in the same direction as the other calming members of an evening blend.

Honokiol and magnolol are positive allosteric modulators at GABA-A receptors, acting at a site distinct from the benzodiazepine pocket. That gives an additive calming effect alongside apigenin rather than a competing one.

Tart cherry carries small native amounts of melatonin along with tryptophan and polyphenols that slow tryptophan degradation down the kynurenine branch. It feeds the same evening pathway from the diet side.

Caffeine blocks adenosine A1 and A2A receptors, which is the accumulating sleep pressure signal a circadian blend is working with, and it also delays the clock phase when taken late. Taken in the same window the two act against each other.

Inulin is fermented by colonic bacteria into short-chain fatty acids, and a 2025 systematic review reports that those acids modulate expression of clock genes in peripheral tissues. The reviewed work is largely preclinical, so this is a mechanistic link rather than a demonstrated effect on human sleep timing. Feeding time also shifts fermentation, which makes the two hard to separate.

Resistant starch reaches the colon undigested and is fermented preferentially to butyrate. The systematic review of short-chain fatty acids and peripheral clock gene expression covers butyrate among the acids studied. Read it as a mechanistic route from diet to peripheral rhythm, measured mostly in animal and cell systems.

Butyrate acts on histone deacetylases and on free fatty acid receptors, both of which touch the machinery that sets peripheral clock gene expression. The review found consistent modulation of that expression across the studies it pooled. These are molecular markers of rhythm in tissue, not measurements of how a person sleeps.

A 2026 systematic review examined how sleep and circadian disruption relate to the composition of gut microbiota and found associations in both directions. Association is not causation here, and the review does not establish that a given strain shifts sleep timing. It supports pairing rhythm-focused ingredients with gut-focused ones as a mechanistic hypothesis.

Bifidobacteria ferment oligosaccharides to acetate and lactate, which cross-feeding species convert onward to butyrate. The reviewed literature links microbiota composition to sleep and circadian measures without isolating single strains. Confidence stays low because strain-level evidence for rhythm endpoints is thin.

Cellular NAD+ rises and falls across the day because the rate-limiting salvage enzyme is under clock control, and the NAD+ dependent deacetylase SIRT1 in turn acts on core clock proteins. Nicotinamide riboside raises NAD+ through that same salvage route. The loop is well described in cell and animal work; a human sleep-timing benefit from raising NAD+ has not been established.

NMN sits one step from NAD+ in the salvage pathway that oscillates with the day and night cycle. Raising the pool alters SIRT1 activity, which is one of the feedback arms on the core clock. This is mechanism from cell biology and does not by itself say anything about how a person sleeps.

Niacin and nicotinamide feed the NAD+ pool through the salvage and de novo routes. Because the salvage enzyme is clock-controlled, NAD+ availability tracks the daily cycle in most tissues. Adequate niacin supports the normal size of that pool; it does not itself set the timing.

Lemon balm appears alongside melatonin and magnesium in evening blends and carries rosmarinic acid and other constituents studied for calm. The pairing is formulation convention with early human data behind the single herb. No combination trial with a rhythm-focused blend supports it.

Passionflower is a long-standing evening herb and is commonly blended with melatonin and amino acids in the same capsule. Human data on the single herb is small and short. Regard the combination as convention rather than a tested pairing.

Valerian is one of the most common partners for melatonin in evening products, and both are associated with reduced alertness. The additive direction matters more than the benefit: anything that lowers alertness stacks with anything else that does. That is worth flagging for anyone driving or on other calming agents.

Chamomile is the main dietary source of apigenin, which already sits in this blend's stored partner list. Pairing the whole herb with the isolated flavone means the same molecule arrives by two routes. Human evidence for chamomile on sleep endpoints remains small.

Cortisol follows a strong daily rhythm, peaking shortly after waking, and ashwagandha has been studied for its effect on cortisol concentration. Cortisol is a marker of the axis, not an outcome in itself. The overlap with rhythm support is the axis, and the pairing is common in evening formulas.

Rhodiola is typically taken in the morning because it is associated with increased alertness, which pulls against the intent of an evening rhythm blend. Taking the two in the same evening dose puts opposing signals into the same window. Separating them by time of day is the usual approach.

Skin synthesis of vitamin D requires ultraviolet exposure, which in practice means daylight, and daylight is also the dominant signal that entrains the central clock. Low vitamin D status therefore often travels with low daytime light exposure. That is an association carried by a shared cause, not evidence that supplementing vitamin D shifts sleep timing.

Zinc is a cofactor across many neuronal enzymes and modulates NMDA receptor function, and it appears in evening formulas alongside magnesium and B6. The cofactor role is textbook; a specific effect of added zinc on rhythm markers in people with adequate status is not established.